Kaleo Release: Pharma Announces U.S. Availability And Pricing To Patients Of AUVI-Q (Epinephrine Injection, USP) Auto-Injector, For Life-Threatening Allergic Reactions Post author:Sam Post published:January 18, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like The Hype Behind Massachusetts Biotech Corbus' Sole Pipeline Drug March 16, 2017 Ionis Pharma Urges Investors to Reject the Below-the-Market Offer By August 23, 2017 The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017
The European Commission (EC) Finally Approves Merck KGaA's Once-Failed MS Drug Cladribine August 24, 2017